Could a pill that calms inflammation also lift depression?

NCT ID NCT07003997

Summary

This study is testing whether a drug called baricitinib, which reduces inflammation, can help improve symptoms of depression in people who have both depression and high levels of inflammation. About 100 adults with depression, low motivation, and a specific blood marker of inflammation will take either baricitinib or a placebo pill for 8 weeks. Researchers will use brain scans and motivation tests to see if the drug improves brain connectivity and reduces symptoms like lack of pleasure and slowed movement.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory University

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact

Conditions

Explore the condition pages connected to this study.